Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 87080

1.

The value of ElastPQ for the evaluation of liver stiffness in patients with B and C chronic hepatopathies.

Mare R, Sporea I, Lupuşoru R, Şirli R, Popescu A, Danila M, Pienar C.

Ultrasonics. 2017 Feb 9;77:144-151. doi: 10.1016/j.ultras.2017.02.005. [Epub ahead of print]

PMID:
28231488
2.

Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.

Liu X, He L, Han J, Wang L, Li M, Jiang Y, Wang X, Yang Z.

PLoS One. 2017 Feb 23;12(2):e0170605. doi: 10.1371/journal.pone.0170605.

3.

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.

Yeh ML, Huang CF, Hsieh MH, Ko YM, Chen KY, Liu TW, Lin YH, Liang PC, Hsieh MY, Lin ZY, Chen SC, Huang CI, Huang JF, Kuo PL, Dai CY, Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2017 Feb 23. doi: 10.1111/jgh.13771. [Epub ahead of print]

PMID:
28230928
4.
5.
6.

Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment.

Li MH, Zhang L, Qu XJ, Lu Y, Shen G, Wu SL, Chang M, Liu RY, Hu LP, Li ZZ, Hua WH, Song SJ, Xie Y.

Chin Med J (Engl). 2017 5th Mar;130(5):559-565. doi: 10.4103/0366-6999.200554.

PMID:
28229987
7.

Capsid Phosphorylation State and Hepadnavirus Virion Secretion.

Ning X, Basagoudanavar SH, Liu K, Luckenbaugh L, Wei D, Wang C, Wei B, Zhao Y, Yan T, Delaney W, Hu J.

J Virol. 2017 Feb 22. pii: JVI.00092-17. doi: 10.1128/JVI.00092-17. [Epub ahead of print]

PMID:
28228589
8.

Three case reports of post immunization and post viral Bullous Pemphigoid: looking for the right trigger.

Baroero L, Coppo P, Bertolino L, Maccario S, Savino F.

BMC Pediatr. 2017 Feb 23;17(1):60. doi: 10.1186/s12887-017-0813-0.

9.

A comparison of multimodal biomarkers for chronic hepatitis B assessment using recursive feature elimination.

Bai Y, Chen X, Dong C, Liu Y, Zhang Z, Yanru Bai, Xin Chen, Changfeng Dong, Yingxia Liu, Zhiguo Zhang, Chen X, Dong C, Zhang Z, Bai Y, Liu Y.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:2448-2451. doi: 10.1109/EMBC.2016.7591225.

PMID:
28227015
10.
11.

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma.

Shen J, Huang CK, Yu H, Shen B, Zhang Y, Liang Y, Li Z, Feng X, Zhao J, Duan L, Cai X.

J Cell Mol Med. 2017 Feb 22. doi: 10.1111/jcmm.12950. [Epub ahead of print] Review.

12.

Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.

Zhu CH, Zhao MZ, Chen G, Qi JY, Song JX, Ning Q, Xu D.

J Huazhong Univ Sci Technolog Med Sci. 2017 Feb;37(1):105-109. doi: 10.1007/s11596-017-1702-3.

PMID:
28224437
13.

Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.

Jeon MY, Lee HW, Kim SU, Heo JY, Han S, Kim BK, Park JY, Kim DY, Ahn SH, Han KH.

Hepatol Int. 2017 Feb 21. doi: 10.1007/s12072-017-9789-y. [Epub ahead of print]

PMID:
28224351
14.

Effects of sex and generation on hepatitis B viral load in families with hepatocellular carcinoma.

Hsieh AR, Fann CS, Yeh CT, Lin HC, Wan SY, Chen YC, Hsu CL, Tai J, Lin SM, Tai DI.

World J Gastroenterol. 2017 Feb 7;23(5):876-884. doi: 10.3748/wjg.v23.i5.876.

15.

To screen or not to screen? Celiac antibodies in liver diseases.

Narciso-Schiavon JL, Schiavon LL.

World J Gastroenterol. 2017 Feb 7;23(5):776-791. doi: 10.3748/wjg.v23.i5.776. Review.

16.

Prodromal fever indicates high risk of liver failure in acute hepatitis B.

Du WJ, Liu L, Sun C, Yu JH, Xiao D, Li Q.

Int J Infect Dis. 2017 Feb 18. pii: S1201-9712(17)30055-3. doi: 10.1016/j.ijid.2017.02.009. [Epub ahead of print]

PMID:
28223176
17.

A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection.

Buchmann B, Döhner K, Schirdewahn T, Sodeik B, Manns MP, Wedemeyer H, Ciesek S, von Hahn T.

Antiviral Res. 2017 Feb 18. pii: S0166-3542(16)30673-8. doi: 10.1016/j.antiviral.2017.02.008. [Epub ahead of print]

PMID:
28223128
18.

Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).

Karabaev BB, Beisheeva NJ, Satybaldieva AB, Ismailova AD, Pessler F, Akmatov MK.

Infect Dis Poverty. 2017 Feb 21;6(1):45. doi: 10.1186/s40249-017-0255-9.

19.

Prevalence of Hepatitis B Antigen/antibody in Patients of Syphilis.

Joshi BN, Jundre S.

Indian J Dermatol Venereol Leprol. 1980 Nov-Dec;46(6):335-337.

PMID:
28218119
20.

Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?

Desalegn H, Aberra H, Berhe N, Gundersen SG, Johannessen A.

Liver Int. 2017 Feb 21. doi: 10.1111/liv.13393. [Epub ahead of print]

PMID:
28222249
Items per page

Supplemental Content

Loading ...
Support Center